Wadih Jordan - Oct 1, 2021 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Director
Signature
/s/ Christine M. Klaskin, as Attorney-in-Fact for Wadih Jordan
Stock symbol
AGEN
Transactions as of
Oct 1, 2021
Transactions value $
$0
Form type
4
Date filed
10/5/2021, 07:19 PM
Previous filing
Jul 2, 2021
Next filing
Jan 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGEN Deferred Stock Units Award +4.56K +2.34% 200K Oct 1, 2021 Common Stock 4.56K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.
F2 Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.
F3 $5.757 per Deferred Stock Unit acquired on October 1, 2021. The price of each Deferred Stock Unit acquired prior to October 1, 2021 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.